Isomer-specific profiling of N-glycans derived from human serum for potential biomarker discovery in pancreatic cancer
- PMID: 29674015
- DOI: 10.1016/j.jprot.2018.04.016
Isomer-specific profiling of N-glycans derived from human serum for potential biomarker discovery in pancreatic cancer
Abstract
Glycosylation is one of the most important post-translational modifications of protein. Recently, global profiling of human serum glycomics has become a noninvasive method for cancer-related biomarker discovery and many studies have focused on compositional glycan profiling. In contrast, structure-specific glycan profiling may provide more potential biomarkers with higher specificity than compositional profiling. In this work, N-glycans released from human serum were neutralized with methylamine and reduced by ammonia-borane complex prior to profiling using nanoLC-ESI-MS with porous graphitized carbon (PGC) and relative abundances of over 280 isomers were compared between pancreatic cancer (PC) cases (n = 32) and healthy controls (n = 32). Statistical analysis identified 25 specific-isomeric biomarkers with significant differences (p-value < 0.05). ROC and PCA analysis were performed to assess the potential biomarkers which were identified as being significantly altered in cancer. The AUCs of the significantly changed specific-isomers were ranging from 0.712 to 0.949. In addition, with the combination of all potential biomarkers, a higher AUC of 0.976 with sensitivity (93.5%) and specificity (90.6%) was obtained. Overall, the proposed strategy coupled to relative quantitative analysis of isomeric glycans make it possible to discover new biomarkers for the diagnosis of PC.
Significance: Pancreatic cancer (PC) has a poor prognosis with a five-year survival rate <5%. Therefore, a strategy for accurate diagnosis of PC is indeed required. In this paper, a dual-derivatized strategy for structure-specific glycan profiling has been used and according to our best knowledge, this is the first application of this strategy for PC biomarker discovery, in which the separation, identification and relative quantification of isomeric glycans can be simultaneously obtained. In addition, by in-depth analysis of isomeric glycans, the full description of the stereo- and region- diversity of glycans can also be achieved, which might provide more potential information for PC biomarker discovery.
Keywords: N-glycans; PC; Potential biomarker; Specific-isomer.
Copyright © 2018 Elsevier B.V. All rights reserved.
Similar articles
-
Isomer-specific biomarker discovery in multiple myeloma with dual-derivatized N-glycans.Anal Bioanal Chem. 2022 Jul;414(18):5617-5626. doi: 10.1007/s00216-022-04010-w. Epub 2022 Mar 23. Anal Bioanal Chem. 2022. PMID: 35320367
-
Validation of N-glycan markers that improve the performance of CA19-9 in pancreatic cancer.Clin Exp Med. 2017 Feb;17(1):9-18. doi: 10.1007/s10238-015-0401-2. Epub 2015 Dec 29. Clin Exp Med. 2017. PMID: 26714469
-
Comprehensive native glycan profiling with isomer separation and quantitation for the discovery of cancer biomarkers.Analyst. 2011 Sep 21;136(18):3663-71. doi: 10.1039/c1an15093f. Epub 2011 Jul 21. Analyst. 2011. PMID: 21776491 Free PMC article.
-
Glycans as cancer biomarkers.Biochim Biophys Acta. 2012 Sep;1820(9):1347-53. doi: 10.1016/j.bbagen.2011.12.001. Epub 2011 Dec 9. Biochim Biophys Acta. 2012. PMID: 22178561 Review.
-
Clinical Glycomics Employing Graphitized Carbon Liquid Chromatography-Mass Spectrometry.Chromatographia. 2015;78(5-6):307-320. doi: 10.1007/s10337-014-2813-7. Epub 2014 Dec 9. Chromatographia. 2015. PMID: 25750456 Free PMC article. Review.
Cited by
-
Deep learning enhanced the diagnostic merit of serum glycome for multiple cancers.iScience. 2023 Dec 13;27(1):108715. doi: 10.1016/j.isci.2023.108715. eCollection 2024 Jan 19. iScience. 2023. PMID: 38226168 Free PMC article.
-
Pancreatic Tumorigenesis: Precursors, Genetic Risk Factors and Screening.Curr Oncol. 2022 Nov 15;29(11):8693-8719. doi: 10.3390/curroncol29110686. Curr Oncol. 2022. PMID: 36421339 Free PMC article. Review.
-
Clinical application of quantitative glycomics.Expert Rev Proteomics. 2018 Dec;15(12):1007-1031. doi: 10.1080/14789450.2018.1543594. Epub 2018 Nov 14. Expert Rev Proteomics. 2018. PMID: 30380947 Free PMC article. Review.
-
Targeted Analysis of Permethylated N-Glycans Using MRM/PRM Approaches.Methods Mol Biol. 2024;2762:251-266. doi: 10.1007/978-1-0716-3666-4_15. Methods Mol Biol. 2024. PMID: 38315370 Free PMC article.
-
Targeting Glycans and Heavily Glycosylated Proteins for Tumor Imaging.Cancers (Basel). 2020 Dec 21;12(12):3870. doi: 10.3390/cancers12123870. Cancers (Basel). 2020. PMID: 33371487 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical